SEC Form 4
Medpace Holdings, Inc. (MEDP) insider trading
In the 12 months to Oct 24, 2026, 9 MEDP insiders reported open-market sales of $467.0M across 39 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $467.0M
- 39 filings · 9 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 1 of 39
- $12.8M of $467.0M sold (3%)
Who traded MEDP, and when
- Sale
- Sale, pre-arranged (10b5-1)
MEDP daily close from Oct 24, 2025 to Oct 23, 2026, between $393.42 and $669.20, last $669.20. 39 sale and 0 purchase filings by 9 insiders, marked at their filing dates. August J. Troendle, CEO → President & CEO: sold $358.5M across 21 filings, first filed Nov 14, 2025, last Oct 1, 2026. Jesse J. Geiger, President: sold $41.1M across 3 filings, first filed Oct 29, 2025, last Mar 19, 2026. Susan E. Burwig, Exec. VP, Operations: sold $28.8M across 4 filings, first filed Oct 29, 2025, last Jul 29, 2026. Stephen P. Ewald, General Counsel & Corp. Secy.: sold $16.5M across 2 filings, first filed Oct 29, 2025, last Jun 1, 2026. Fred B. Davenport Jr., Director: sold $7.9M across 2 filings, first filed Nov 3, 2025, last Aug 21, 2026. Robert O. Kraft, Director: sold $6.2M across 2 filings, first filed Nov 18, 2025, last Aug 28, 2026. 3 others: sold $8.1M across 5 filings, first filed Nov 25, 2025, last Aug 24, 2026.
Largest mark · tap a row for others
August J. Troendle · CEO
Filing 1 of 2 within a week · $78,998,895 total
Sale $17,031,557
28,688 shares at $593.68 avg
Filed Nov 24, 2025 · traded Nov 20
Close on filing date $618.49
August J. Troendle · CEO → President & CEO
CEO → President & CEO
$358.5M soldJesse J. Geiger · President
President
$41.1M soldSusan E. Burwig · Exec. VP, Operations
Exec. VP, Operations
$28.8M soldStephen P. Ewald · General Counsel & Corp. Secy.
General Counsel & Corp. Secy.
$16.5M soldFred B. Davenport Jr. · Director
Director
$7.9M soldRobert O. Kraft · Director
Director
$6.2M sold3 others
Combined, one mark per week
$8.1M soldHas Medpace Holdings, Inc.'s CEO sold stock?
Yes. August J. Troendle (CEO) sold 586,377 shares ($358.5M) between Nov 2025 and Oct 2026.
Open-market trades
39 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| August J. Troendle | CEO → President & CEO | $358.5M | — | 21 | — | |
| Jesse J. Geiger | President | $41.1M | — | 3 | 31% of sales | |
| Susan E. Burwig | Exec. VP, Operations | $28.8M | — | 4 | — | |
| Stephen P. Ewald | General Counsel & Corp. Secy. | $16.5M | — | 2 | — | |
| Fred B. Davenport Jr. | Director | $7.9M | — | 2 | — | |
| Robert O. Kraft | Director | $6.2M | — | 2 | — | |
| Kevin M. Brady | CFO & Treasurer | $3.9M | — | 2 | — | |
| Brian T. Carley | Director | $3.0M | — | 1 | — | |
| Cornelius P. McCarthy III | Director | $1.2M | — | 2 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | August J. Troendle President & CEO | Sale | 48,667 | $623.03 | $30.3M | 338,225 | |
traded | August J. Troendle President & CEO | Sale | 2,564 | $620.10 | $1.6M | 386,892 | |
traded | August J. Troendle President & CEO | Sale | 43,916 | $624.01 | $27.4M | 389,456 | |
traded | August J. Troendle President & CEO | Sale | 70,901 | $626.62 | $44.4M | 433,372 | |
traded | August J. Troendle President & CEO | Sale | 10,880 | $620.40 | $6.7M | 504,273 | |
traded | August J. Troendle President & CEO | Sale | 24,741 | $621.00 | $15.4M | 515,153 | |
traded | August J. Troendle President & CEO | Sale | 650 | $620.27 | $403.2K | 539,894 | |
traded | Robert O. Kraft Director | Sale | 3,858 | $617.81 | $2.4M | 955 | |
traded | August J. Troendle President & CEO | Sale | 4,673 | $620.08 | $2.9M | 540,544 | |
traded | August J. Troendle President & CEO | Sale | 15,978 | $623.93 | $10.0M | 545,217 | |
traded | Kevin M. Brady CFO & Treasurer | Sale | 3,400 | $625.24 | $2.1M | 12,830 | |
traded | Fred B. Davenport Jr. Director | Sale | 7,283 | $606.15 | $4.4M | 3,798 | |
traded | Brian T. Carley Director | Sale | 5,000 | $608.63 | $3.0M | 27,825 | |
traded | August J. Troendle President & CEO | Sale | 42,783 | $614.30 | $26.3M | 561,195 | |
traded | August J. Troendle President & CEO | Sale | 11,824 | $601.49 | $7.1M | 603,978 | |
traded | Cornelius P. McCarthy III Director | Sale | 1,140 | $605.37 | $690.1K | 12,275 | |
traded | August J. Troendle President & CEO | Sale | 23,144 | $604.25 | $14.0M | 615,802 | |
traded | Cornelius P. McCarthy III Director | Sale | 795 | $585.07 | $465.1K | 13,415 | |
traded | August J. Troendle President & CEO | Sale | 7,238 | $600.44 | $4.3M | 638,946 | |
traded | Susan E. Burwig Exec. VP, Operations | Sale | 7,500 | $600.00 | $4.5M | 62,984 | |
traded | Stephen P. Ewald General Counsel & Corp. Secy. | Sale | 16,349 | $450.00 | $7.4M | 20,343 | |
traded | Jesse J. Geiger President | Sale | 31,707 | $455.30 | $14.4M | 15,000 | |
traded | August J. Troendle CEO | Sale | 668 | $590.69 | $394.6K | 646,184 | |
traded | August J. Troendle CEO | Sale | 28,876 | $592.70 | $17.1M | 646,852 | |
traded | August J. Troendle CEO | Sale | 56,482 | $603.28 | $34.1M | 675,728 | |
traded | August J. Troendle CEO | Sale | 101,417 | $611.02 | $62.0M | 732,210 | |
traded | Susan E. Burwig Exec. VP, Operations | Sale | 20,000 | $609.15 | $12.2M | 27,500 | |
traded | Kevin M. Brady CFO & Treasurer | Sale | 3,000 | $590.35 | $1.8M | 6,000 | |
traded | August J. Troendle CEO | Sale | 28,688 | $593.68 | $17.0M | 833,627 | |
traded | August J. Troendle CEO | Sale | 31,053 | $591.79 | $18.4M | 862,315 | |
traded | Robert O. Kraft Director | Sale | 6,472 | $591.85 | $3.8M | 833 | |
traded | August J. Troendle CEO | Sale | 20,794 | $594.02 | $12.4M | 893,368 | |
traded | August J. Troendle CEO | Sale | 10,440 | $602.32 | $6.3M | 914,162 | |
traded | Susan E. Burwig Exec. VP, Operations | Sale | 18,000 | $605.00 | $10.9M | 47,500 | |
traded | Jesse J. Geiger President | SalePre-arranged (10b5-1) | 21,503 | $595.66 | $12.8M | 15,000 | |
traded | Fred B. Davenport Jr. Director | Sale | 5,972 | $581.88 | $3.5M | 3,498 | |
traded | Stephen P. Ewald General Counsel & Corp. Secy. | Sale | 15,230 | $598.85 | $9.1M | 13,343 | |
traded | Jesse J. Geiger President | Sale | 23,028 | $602.00 | $13.9M | 36,503 | |
traded | Susan E. Burwig Exec. VP, Operations | Sale | 2,000 | $605.01 | $1.2M | 65,500 |
GET /stocks/filings/vX/form-4?tickers=MEDP&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"MEDP"
],
"issuer_cik": "0001668397",
"owner_cik": "0001622058",
"accession_number": "0001622058-26-000022",
"form_type": "4",
"filing_date": "2026-10-01",
"period_of_report": "2026-09-29",
"issuer_name": "Medpace Holdings, Inc.",
"issuer_trading_symbol": "MEDP",
"owner_name": "Troendle August J.",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "President & CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-30",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 21966,
"transaction_price_per_share": 625.47,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 338225,
"transaction_value": 13739074.020000001,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period."
},
{
"id": "F3",
"description": "The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.105 to $628.08. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request."
}
]
},
{
"tickers": [
"MEDP"
],
"issuer_cik": "0001668397",
"owner_cik": "0001622058",
"accession_number": "0001622058-26-000022",
"form_type": "4",
"filing_date": "2026-10-01",
"period_of_report": "2026-09-29",
"issuer_name": "Medpace Holdings, Inc.",
"issuer_trading_symbol": "MEDP",
"owner_name": "Troendle August J.",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": true,
"is_other": false,
"officer_title": "President & CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-09-29",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 26701,
"transaction_price_per_share": 621.02,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 360191,
"transaction_value": 16581855.02,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period."
},
{
"id": "F2",
"description": "The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $620.00 to $622.35. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request."
}
]
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 38 records
- Option exercises37 records
- Gifts1 record
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for MEDP every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Role
- The title on each filing. Someone whose title changed shows more than one.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.